About Contact Us Careers

Atropine Sulfate Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 2535
Published Date: Oct 14, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Atropine Sulfate Landscape

Meridian Medical Technologies, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Novartis AG
Teligent
C²PHARMA
RESONANCE LABORATORIES
China Resources Double-crane Pharmaceutical Co., Ltd.
Albany Molecular Research Inc.
Alchem International Pvt. Ltd.
Saurav Chemicals Ltd.
Wuhan senwayer century chemical Co., Ltd.

Browse Key Market Insights with Data Illustration:

Atropine Sulfate Market Size & Share, Growth Analysis 2036

In the News

Author Credits: Radhika Pawar

Report ID: 2535
Published Date: Oct 14, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of atropine sulfate is evaluated at USD 105.25 million.

Atropine Sulfate Market size was over USD 101.36 million in 2023 and is poised to exceed USD 186.45 million by 2036, witnessing over 4.8% CAGR during the forecast period i.e., between 2024-2036.

North America industry is poised to account for largest revenue share by 2036, propelled by presence of some of the key players that are also traditional suppliers of medicinal drugs.

The major players in the market are Meridian Medical Technologies, Inc., Novartis AG, Teligent, CÂ²PHARMA, RESONANCE LABORATORIES, China Resources Double-crane Pharmaceutical Co., Ltd., Albany Molecular Research Inc., Alchem International Pvt. Ltd., Saurav Chemicals Ltd., Wuhan senwayer century chemical Co., Ltd., and others.

Inquiry Before Buying Request Free Sample